- cafead Jul 08, 2024 at 11:52: AM
via Spanish fertility biotech, Oxolife has presented positive exploratory Phase II data for its non-hormonal fertility pill, OXO-001, in patients who underwent in vitro fertilisation (IVF).
The placebo-controlled Phase II OXOART2 trial (NCT05076032) evaluated OXO-001 in women up to 40 years of age, who all underwent single embryo transfer using donor eggs. The exploratory analysis consisted of data from 96 women.
article source
The placebo-controlled Phase II OXOART2 trial (NCT05076032) evaluated OXO-001 in women up to 40 years of age, who all underwent single embryo transfer using donor eggs. The exploratory analysis consisted of data from 96 women.
article source